Dialysis Market
Dialysis Market Size, Share & Industry Analysis, By Type (Hemodialysis, Peritoneal Dialysis), By Product (Machines, Consumables, Services), By End User (Hospitals, Dialysis Centers, Home Care Settings), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) - Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview:
The global dialysis market is projected to grow at a CAGR of 5.7% from 2024 to 2031. The market value is expected to increase from USD XX billion in 2024 to USD YY billion by 2031. North America currently dominates the market, accounting for the largest share of global revenue. Key metrics include the rising prevalence of chronic kidney diseases, technological advancements in dialysis equipment, and increasing government initiatives to improve renal care.
The dialysis industry is expanding steadily, owing to an increase in the global incidence of end-stage renal disease (ESRD). Factors like as an ageing population, rising cases of diabetes and hypertension, and improved access to dialysis therapy in emerging nations all contribute to market growth.
Market Dynamics:
Market Trend: Shift towards home-based dialysis treatment options gaining momentum
The dialysis market is seeing a considerable shift towards home-based dialysis therapies, specifically peritoneal dialysis and home haemodialysis. This transition is being driven by factors such as increased patient comfort, lower risk of hospital-acquired illnesses, and a higher quality of life. The COVID-19 epidemic has intensified this trend, as patients attempt to limit their exposure to healthcare environments. Home dialysis also provides greater treatment schedule flexibility, allowing patients to continue their regular work and social activities. Healthcare providers and payers are increasingly supportive of this transformation, recognising the potential for cost savings and better patient outcomes. Technological developments in dialysis machines and remote monitoring capabilities are accelerating the use of home-based treatments, making them more accessible and manageable for patients and carers.
Market Driver: Rising prevalence of chronic kidney disease and end-stage renal disease
The rising frequency of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a major driver of dialysis market expansion. According to the Global Burden of Disease Study, the number of CKD cases globally grew by 29.3% between 1990 and 2017, totalling 697.5 million. The growing older population, rising incidences of diabetes and hypertension, and improved diagnostic rates all contribute to this increase. According to the US Renal Data System, more than 785,000 people in the United States had ESRD in 2018, with around 71% of these patients undergoing dialysis treatment. The economic impact of ESRD is significant, with Medicare spending on ESRD patients in the United States totalling $36.6 billion in 2018. As the number of patients requiring dialysis grows, healthcare systems around the world are expanding their dialysis infrastructure and services to meet the increased demand.
Market Restraint: High cost of dialysis treatment and equipment
The high cost of dialysis therapy and equipment is a key barrier to industry growth. The average annual cost of haemodialysis treatment per patient in the United States is approximately $90,000. In poor countries, the cost burden is significantly higher in comparison to income levels. The cost of dialysis machines, consumables, and qualified people adds to the total treatment cost. Many patients, especially in low- and middle-income countries, cannot afford long-term dialysis treatment, resulting in limited access and inadequate care.
Segment Overview:
Hemodialysis dominates the global dialysis market, accounting for the largest share of revenue.
Haemodialysis is still the most often used dialysis modality in the world, because to reasons such as its efficacy in eliminating waste materials and excess fluids from the blood, established infrastructure, and familiarity among healthcare providers. The segment's dominance is bolstered by technological advances in haemodialysis machines, which have increased treatment efficiency and patient comfort.
Recent advancements in haemodialysis technology have focused on improving treatment outcomes and the patient experience. For example, in 2019, Fresenius Medical Care developed the 4008A dialysis machine, which is specifically built for emerging economies and combines cost-efficiency with high treatment quality requirements. This introduction increased access to haemodialysis in areas with inadequate healthcare resources.
The haemodialysis market has also seen significant increase in home-based treatments. According to the United States Renal Data System, the number of patients getting home haemodialysis in the United States increased by 16% from 2017 to 2018. This trend is being assisted by the development of more compact and user-friendly home haemodialysis devices, such as NxStage's System One, which has grown in favour among patients looking for more treatment options.
Regional Outlook:
North America leads the global dialysis market, with the United States being the largest contributor to regional revenue.
North America's dominance in the dialysis industry is due to factors such as a high prevalence of chronic renal disease, well-established healthcare infrastructure, and favourable reimbursement laws. The area benefits from enhanced technology adoption and a large number of important industry participants.
Recent market developments in North America include the growth of dialysis clinic networks. For example, in 2023, DaVita Inc. will open 18 additional dialysis centres across the United States, expanding patient access to service.
Key data show the market's importance in North America. According to the United States Renal Data System, Medicare spending on ESRD patients totalled $37.3 billion in 2019, or 7% of the overall Medicare budget. Additionally, the number of dialysis centres in the United States increased by 3.5% between 2018 and 2019.
Canada's dialysis market has grown significantly as well. The Canadian Institute for Health Information showed a 35% increase in the number of Canadians receiving dialysis treatment between 2010 and 2019, indicating an increasing demand for renal care services in the country.
Competitive Intelligence:
The worldwide dialysis market is dominated by a number of large multinational firms and regional players. Fresenius Medical Care, DaVita Inc., Baxter International, and B. Braun Melsungen AG are among the market's leading players. These companies have built significant market positions through diverse product offerings, global distribution networks, and strategic alliances.
Fresenius Medical Care has the greatest market share, with a strong presence in both products and services. The company has over 4,000 dialysis clinics worldwide and has been focussing on developing its home dialysis services. DaVita Inc. follows closely, with a significant presence in the US market and expanding overseas operations.
Recent market developments have centred on technical advancements to improve treatment outcomes and patient quality of life. For example, Baxter International has invested in the development of automated peritoneal dialysis devices, which make home-based treatments more convenient.
Mergers and acquisitions have been an important technique for market expansion. Fresenius Medical Care expanded its service network in the United States by acquiring additional dialysis clinics in 2021. Similarly, B. Braun Melsungen AG has increased its position in emerging areas through strategic alliances and acquisitions.
The dialysis market's future prognosis is good, with development prospects in home-based dialysis systems, value-based care models, and emerging regions. Companies are projected to continue investing in R&D to meet unmet renal care requirements and increase treatment efficiency.
Analyst Opinion:
The dialysis industry is poised for major transition in the next years, owing to technology developments and shifting patient preferences. One unique development to watch is the incorporation of artificial intelligence and machine learning into dialysis therapy. These technologies offer the ability to optimise treatment settings, forecast complications, and personalise care regimens, resulting in better patient outcomes and lower healthcare costs.
Another important trend is the increased emphasis on sustainability in dialysis practices. As environmental concerns gain traction, dialysis providers are looking into ways to cut water use, reduce waste generation, and provide eco-friendly dialysis systems. This trend not only corresponds with global sustainability goals, but it also opens up long-term prospects for innovation and cost savings.
Major Players:
-
Fresenius Medical Care AG & Co. KGaA
-
DaVita Inc.
-
Baxter International Inc.
-
B. Braun Melsungen AG
-
Nipro Corporation
-
Nikkiso Co., Ltd.
-
Asahi Kasei Corporation
-
Toray Industries, Inc.
-
Becton, Dickinson and Company
-
Medtronic plc
Key Developments:
-
In June 2023, Fresenius Medical Care debuted its next-generation 6008 CAREset dialysis equipment in select European markets, which includes enhanced fluid management features.
-
In March 2023, DaVita Inc. announced a collaboration with a top telehealth provider to extend remote monitoring capabilities for home dialysis patients.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium)
5. COMPANY PROFILES
5.1. Fresenius Medical Care AG & Co. KGaA
5.2. DaVita Inc.
5.3. Baxter International Inc.
5.4. B. Braun Melsungen AG
5.5. Nipro Corporation
5.6. Nikkiso Co., Ltd.
5.7. Asahi Kasei Corporation
5.8. Toray Industries, Inc.
5.9. Becton, Dickinson and Company
5.10. Medtronic plc (LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards home-based dialysis treatment options gaining momentum
6.1.2. Integration of artificial intelligence and machine learning in dialysis care
6.1.3. Growing emphasis on sustainability in dialysis practices
6.2. Market Drivers
6.2.1. Rising prevalence of chronic kidney disease and end-stage renal disease
6.2.2. Technological advancements in dialysis equipment
6.2.3. Increasing government initiatives to improve renal care
6.3. Market Restraints
6.3.1. High cost of dialysis treatment and equipment
6.3.2. Shortage of skilled nephrologists and dialysis technicians
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Hemodialysis
7.1.1. In-center Hemodialysis
7.1.2. Home Hemodialysis
7.2. Peritoneal Dialysis
7.2.1. Continuous Ambulatory Peritoneal Dialysis (CAPD)
7.2.2. Automated Peritoneal Dialysis (APD)
8. BY PRODUCT (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Machines
8.1.1. Hemodialysis Machines
8.1.2. Peritoneal Dialysis Machines
8.2. Consumables
8.2.1. Dialyzers
8.2.2. Catheters
8.2.3. Concentrates/Dialysates
8.2.4. Other Consumables
8.3. Services
8.3.1. In-center Dialysis Services
8.3.2. Home Dialysis Services
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Hospitals
9.2. Dialysis Centers
9.3. Home Care Settings
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
Dialysis Market Segmentation:
By Type:
-
Hemodialysis
-
Peritoneal Dialysis
By Product:
-
Machines
-
Consumables
-
Services
By End User:
-
Hospitals
-
Dialysis Centers
-
Home Care Settings
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511